Christopher Phd Walsh Insider Profile
4 Followers
Christopher Phd Walsh, Director at Ironwood Pharma, holds 349.95K shares in Ironwood Pharma (Ticker: IRWD), holds ― shares in Kineta (Ticker: KANT), holds 0.00 shares in Achaogen (Ticker: AKAOQ).
Christopher Phd Walsh's Trading History
| IRWDIronwood Pharma | Mar 16, 2017 | Director | Uninformative Buy | ― | $1.69M | |
| ~CRTXCornerstone Therapeutics Inc | ― | ― | ― | ― | ||
| AKAOQAchaogen | ― | ― | ― | $0.00 | ||
| KANTKineta | ― | ― | ― | ― |
You May Also Like
Christopher Phd Walsh insider profile FAQ
What is the percentage of profitable transactions made by Christopher Phd Walsh?
The percentage of profitable transactions made by Christopher Phd Walsh is 67%.
What is the average return per transaction made by Christopher Phd Walsh?
The average return per transaction made by Christopher Phd Walsh is 4.70%.
What stocks does Christopher Phd Walsh hold?
Christopher Phd Walsh holds: IRWD, KANT, AKAOQ, ~CRTX stocks.
What was Christopher Phd Walsh's most profitable transaction?
Christopher Phd Walsh’s most profitable transaction was an Informative Buy of IRWD stock on February 11, 2011. The return on the trade was 28.20%.
What is Christopher Phd Walsh's role in Ironwood Pharma?
Christopher Phd Walsh's role in Ironwood Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
